Cargando…
Pharmacokinetics of biologics in gastric cancer
Gastric cancer (GC) remains one of the leading causes of cancer death worldwide despite improvements in therapeutic options. Several biologics have been investigated in patients with GC, including those approved in other solid tumors; however, the success rate of the pivotal trials that investigated...
Autores principales: | Li, Junyi, Turner, David C., Li, Feifei, Chen, Xi, Liao, Michael Z., Li, Chunze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087068/ https://www.ncbi.nlm.nih.gov/pubmed/36631818 http://dx.doi.org/10.1111/cts.13474 |
Ejemplares similares
-
Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates
por: Li, Chunze, et al.
Publicado: (2020) -
Pharmacokinetics and Biological Activity of Cucurbitacins
por: Delgado-Tiburcio, Eugenia Elisa, et al.
Publicado: (2022) -
Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug Conjugates?
por: Liao, Michael Z., et al.
Publicado: (2021) -
Iridoids: Research Advances in Their Phytochemistry, Biological Activities, and Pharmacokinetics
por: Wang, Congcong, et al.
Publicado: (2020) -
Evaluation of Pharmacokinetics of Boronophenylalanine and Its Uptakes in Gastric Cancer
por: Tang, Futian, et al.
Publicado: (2022)